← Evidence map

ReviewMedical oncology (Northwood, London, England)2022

Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations.

Azmi YerlikayaPubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35568791